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Background: Nowadays, patients are expected to be involved in their health care, well-informed and able to
adjust their behavior to maintain a good health. Investigating patient activation and its relationships with patient
characteristics and health-related outcomes will provide further insight into the gains to be expected if patients are
more involved in their healthcare.
Methods: Based on claims data, 5,346 people were selected who received diabetes care in the last 12 months.
They received a questionnaire including the Patient Activation Measure (PAM) and questions on patient
characteristics, life style and self-management behaviors, knowledge about diabetes, healthcare utilization and own
clinical values. We used bivariate analyses and regression analyses to investigate the relationships between patient
characteristics, patient activation level, and health-related outcomes.
Results: Data of 1,845 (35%) people were used in the analyses. Patient activation differed depending upon
several patient characteristics. Patient activation level was positively related to getting the recommended feet
and eye examinations after controlling for several patient characteristics; no association was found for life-style
and self-management behaviors and the other healthcare utilization measures. Those with a low patient activation
level less often reported to have knowledge about diabetes and of their values on clinical indicators.
Conclusions: Among people with diabetes, patient activation level was especially related to disease-specific
knowledge and less with health-related behavior and outcomes. The PAM might therefore especially be an useful
instrument for clinical practice to identify patients most in need for diabetes education.
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Patients and especially the chronically ill are more and
more expected to be in charge of their own health and the
healthcare they receive. For one, several western countries
have introduced some form of managed competition in
their healthcare system with the aim to accomplish a more
efficient and more patient-centered healthcare system. Pa-
tients are expected to take more responsibility, to inform
themselves about existing treatments and differences in
quality of care between healthcare providers, and to choose
the treatment and provider that best meet their needs.* Correspondence: m.hendriks@nivel.nl
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article, unless otherwise stated.Also, the Chronic Care Model has been introduced to
help healthcare providers to improve patients’ health out-
comes [1,2]. One important element is to accomplish pro-
ductive interactions that help patients to set goals and
solve problems for improved self-management. Healthcare
professionals should mainly act as coaches, providing pa-
tients with information and helping them to develop skills
to take a leading role [3,4]. Both these trends ask for active
patients; patients who are involved in their own health
care, well-informed and able to adjust their behavior to
realize or maintain a good health. For the chronically ill, it
additionally means employing self-management activities
such as monitoring one’s condition, self-treatment and co-
ordinating the care of different providers [5].Med Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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tions and a major cause of morbidity, disability and mor-
tality [6]. Self-management has been recognized as an
important contributor to improved health outcomes for
people with diabetes [7]. However, not all people are
equally well equipped to perform the variety of activities
required for proper self-management. Educating and
training people to fulfill the role of active patient is as-
sumed to have positive effects on health outcomes. It
will also most likely enhance the sustainability of health-
care systems. More activated patients will be better able
to self-manage their disease leading to a lower uptake of
more costly health care [7-9].
In order to enhance the activation level of people with
diabetes or a chronic illness in general, an instrument is
needed to assess their abilities to manage their disease.
Hibbard and colleagues developed the Patient Activation
Measure (PAM) for this purpose. They define patient acti-
vation as someone’s knowledge, skills, confidence and be-
haviors needed for self-managing one’s condition or health
[9,10]. Research suggests that people go through four
stages of patient activation. At stage 1, people tend to be
overwhelmed and unprepared to play an active role, they
are predisposed to be passive recipients of care. At stage 2,
individuals lack knowledge and confidence for self-
management. At stage 3, people are beginning to take ac-
tion but may still lack confidence and skills to support
new behaviors. Finally, at stage 4, people have confidence
and perform adequate behaviors but may not be able to
maintain them in the face of stress.
Patients with a higher activation level are more likely to
engage in healthy behaviors such as regular exercise and
proper diet, to engage in disease-specific self-management
behaviors, to report medication adherence and to obtain
preventive care [8,11,12]. Higher patient activation also
appears to be related with better biometrics such as blood
pressure and lipoprotein levels within a normal range and
with less hospitalizations and emergency department visits
[8]. Several studies have shown that care tailored to a pa-
tient’s activation level as measured with the PAM resulted
in improved values on clinical indicators, higher adher-
ence to medication regimens and a reduction in hospitali-
zations and emergency department visits [8,13]. Also,
patient activation appeared to be modifiable and increases
in activation were followed by improvement in self-
management behaviors [13,14].
Up till now, only a few studies focused on the activa-
tion level of people with diabetes. These studies have
shown that patient activation is related to age, gender,
race/ethnicity, self-reported health, duration and severity
of the disease and comorbidity [6,7,15]. Patient activa-
tion was also related to life-style and self-management
behaviors and healthcare utilization of people with dia-
betes. Rask et al., for instance, found that more activepatients reported higher rates of weekly feet checks, get-
ting recommended eye examinations, regular exercise and
ease of managing diabetes [15]. An Australian study re-
vealed that individuals with a lower patient activation level
were more likely to have been hospitalized for diabetes-
related complaints or to have visited the emergency de-
partments [7]. So far, there has been one longitudinal
study showing that a high activation level was predictive
of better rates for hemoglobin A1C (HbA1C) checkups,
low-density lipoprotein cholesterol (LDL-C) checkups,
HbA1C control and all-cause inpatient discharges [6]. Pa-
tient activation did not predict lipid-lowering drug use,
LDL-C control and hospital discharges with a primary
diagnose of acute myocardial infarction.
In short, previous studies among diabetes patients have
shown that patient activation as measured with the PAM
is related to patient characteristics and to health-related
outcomes. However, studies with the PAM are scarce, es-
pecially outside the USA. Investigating patient activation
and its relationships with health-related outcomes in dif-
ferent patient groups and countries will provide further
insight into the gains to be expected if patients are more
involved in their healthcare. In this study, we focused on
people with diabetes in the Netherlands and determined
the relationships between patient characteristics, health-
related outcomes and patient activation. We will answer
the following questions: (1) What is the activation level of
Dutch people with diabetes; and (2) How does patient ac-
tivation relate to patient characteristics and self-reported
health-related outcomes in this group?
Methods
Subjects and design
As part of a larger study on patients’ experiences with dia-
betes care, 23,074 people who received diabetes care in
2010 were selected from claims data of six health insur-
ance companies. The health insurance companies selected
individuals who claimed costs for diabetes care provided
in 61 selected diabetes care networks from April to De-
cember 2010. Next, people younger than 18 years and/or
who were approached in the past 12 months for other sur-
veys on patient experiences were excluded. Each health in-
surance company randomly selected 300 patients per
diabetes care network. If less than 300 patients received
care from one of the networks all patients were selected
with a minimum of 80 patients per network. This resulted
in the total of 23,074 people.
The individuals received a paper questionnaire at home
in the beginning of 2011 and non-respondents received up
to three reminders (Dillman method) [16]. The question-
naire included questions on patient characteristics, experi-
ence with diabetes care and health-related outcomes. A
subgroup of 5,346 people received a questionnaire that
also contained the PAM. Ethical approval of the study was
Table 1 Original American version of 13 item Patient
Activation Measure
1 When all is said and done, I am the person who
is responsible for managing my health condition
2 Taking an active role in my own healthcare is
the most important factor in determining my
health and ability to function
3 I am confident that I can take actions that will
help prevent or minimize some symptoms or
problems associated with my health condition
4 I know what each of my prescribed medications do
5 I am confident that I can tell when I need to go
get medical care and when I can handle a health
problem myself
6 I am confident I can tell my healthcare provider
concerns I have even when he or she does not ask
7 I am confident that I can follow through on medical
treatments I need to do at home
8 I understand the nature and causes of my health
condition(s)
9 I know the different medical treatment options
available for my health condition
10 I have been able to maintain the lifestyle changes
for my health that I have made
11 I know how to prevent further problems with my
health condition
12 I am confident I can figure out solutions when new
situations or problems arise with my health condition
13 I am confident that I can maintain lifestyle changes
like diet and exercise even during times of stress
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taxing or hazardous for patients (i.e. the once-only com-
pletion of a questionnaire containing questions that do
not constitute a serious encroachment on the respondent)
is not subject to the Dutch Medical Research Involving
Human Subjects Act (WMO).
Patient characteristics
The following demographic data were collected: (1) gen-
der; (2) age in eight categories reclassified as 18–54
years, 55–64 years, 65–74 years, 75 years and older; (3)
education level in eight categories reclassified as low (no
education through lower vocational education), middle
(intermediate secondary through higher secondary edu-
cation) and high (higher vocational education or univer-
sity); (4) ethnicity (Dutch, Western, or non-Western); (5)
spoken language at home (Dutch or other); (6) disease
duration, that is time since the diagnosis of diabetes was
established (less than 12 months, 1 to 2 years, 2 to
10 years or more than 10 years); and (7) self-reported
health status (poor, fair, good, very good or excellent).
Health-related outcomes
Life style and self-management behaviors
Respondents were asked whether they smoke (no or yes)
and whether they check their own blood glucose level
(no or yes).
Self-perceived knowledge about diabetes
The questionnaire had three questions concerning
knowledge about diabetes: whether the person knows
what type of diabetes he/she has (no or yes), knows
which side-effects of medications he/she should attend
to (no, not really, on the whole yes or yes) and knows
which actions to take when his/her blood glucose level is
too high (no, not really, on the whole yes or yes).
Healthcare utilization
The use of routine checkups was assessed with five ques-
tions on how long ago the following checkups had taken
place: blood sample to check HbA1C level, blood sample
to check cholesterol level, blood pressure measurement by
healthcare provider, feet check by doctor and eye examin-
ation. Dutch guidelines for diabetes care prescribe that all
checkups except the eye examination take place at least
once every year; eye examinations have to take place at
least once every two years. Following these guidelines, we
used the following answer categories for all checkups ex-
cept the eye examination: within the past 12 months
(reflecting proper diabetes care), over 12 months ago or
never, or don’t know. For eye examination the following
categories were used: within the past 24 months (reflecting
proper diabetes care), over 24 months ago or never, or
don’t know.Self-reported values on clinical indicators
Respondents were asked to indicate their HbA1C value
(between 2-7% (0–53 mmol/mol), between 7-9% (53–
75 mmol/mol), between 9-24% (75–240 mmol/mol) or
don’t know), diastolic blood pressure (lower than 90, 90
or higher or don’t know) and systolic blood pressure
(lower than 140, 140 or higher or don’t know) as mea-
sured during the last measurement.
Patient Activation Measure (PAM)
The PAM 13-Dutch consists of 13 items assessing know-
ledge, skill and confidence for self-care [17]; see Table 1
for the original American version. The PAM has recently
been translated in Dutch and validated in a sample of
chronically-ill people including people with diabetes and a
sample of the general population [17,18]. All items have
five possible responses with scores ranging from 0 to 4; (1)
disagree strongly, (2) disagree, (3) agree, (4) agree strongly
or (0) not applicable. Internal consistency of the PAM in
this study was good (Cronbach’s alpha = 0.86).
For calculating patients’ PAM score, we followed the
guidelines of Insignia Health [19]. Participants who filled
out less than seven questions or answered all items with
disagree strongly or agree strongly were excluded. We
Table 2 Bivariate relations between patient
characteristics and the Patient Activation Measure (PAM)
N % Mean PAM (SD) p-value
Total 1,845 57.4 (14.3)
Gender 1,810 0.017
Male 856 47.3 58.1 (14.3)
Female 954 52.7 56.5 (14.2)
Age 1,820 <0.001
18-54 years 305 16.8 59.6 (14.1)
55-64 years 512 28.1 57.8 (14.3)
65-74 years 573 31.5 57.3 (14.3)
75 years and older 430 23.6 55.2 (14.0)
Education level 1,732 <0.001
Low 997 57.6 56.5 (14.2)
Middle 634 36.6 58.0 (13.8)
High 101 5.8 62.7 (15.6)
Ethnicity 1,820 0.555
Dutch 1,454 79.9 57.5 (14.5)
Western 133 7.3 56.2 (14.0)
Non-Western 233 12.8 57.0 (13.4)
Spoken language at home 1,753 0.008
Dutch 1,617 92.2 57.6 (14.5)
Other 136 7.8 54.2 (11.8)
Disease duration 1,711 0.352
Less than 12 months 156 9.1 56.2 (14.3)
1 year up to 2 years 154 9.0 58.9 (14.9)
2 years up to 10 years 906 53.0 57.2 (14.0)
More than 10 years 495 28.9 57.7 (14.7)
General health status 1,817 <0.001
Poor 70 3.9 47.3 (13.5)
Fair 577 31.8 53.1 (13.0)
Good 1,014 55.8 59.1 (13.9)
Very good 117 6.4 65.0 (14.6)
Excellent 39 2.1 69.8 (15.7)
Note. Bold values indicate a p-value < 0.05.
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items deemed not applicable by the respondents. This
mean score was transformed into a standardized activation
score ranging from 0 to 100, the PAM score. Next, the
PAM score was converted into the four levels of patient ac-
tivation conform the scoring rules of Insignia Health [19].
Statistical analyses
Bivariate analyses were conducted to investigate the rela-
tionship between patient characteristics, health-related
outcomes and the PAM score. A two-sample t-test was
used to test for significant differences in PAM score for
binary variables and one-way ANOVA was used for cat-
egorical variables with three or more groups.
Using Stata 13.1, we performed regression analyses to
evaluate the relationship between the PAM level (pre-
dictor variable with PAM level 1 as reference group) and
each of the health-related outcomes (dependent variables)
while controlling for patient characteristics. Logistic re-
gression analyses were used for the binary health-related
outcomes, that is smoking status, self-checking blood glu-
cose level and knowledge of type of diabetes. For the
health-related outcomes with three or more groups, we
performed ordered logistic regression analyses in case the
response categories were ordered (i.e., knowledge about
side-effects of medicines and knowledge about what to do
when blood glucose level is too high) and multinomial lo-
gistic regression analyses in case the response categories
had no natural ordering (i.e. outcomes concerning health-
care utilization and self-reported clinical values).
Results
Respondents
The response of the total study was 8,609 (response rate
37%). The group of respondents consisted of signifi-
cantly more men than the group of non-respondents
(48% versus 44%). Also, mean age was significantly lower
in the group of respondents, but the difference with the
group of non-respondents was less than 2.5 months.
1,969 of the 5,346 patients filled out the PAM. A total
of 1,845 (response rate 35%) questionnaires were used
for statistical analyses. 124 participants (6.3%) were ex-
cluded from the analyses; 72 participants because they
answered less than seven of the PAM items and 52 par-
ticipants since they responded to all items identically.
About half of the respondents were male (see Table 2).
Most respondents were 55 years or older, had a low to
middle education level, were of Dutch origin and spoke
Dutch at home. For most respondents the diagnosis
of diabetes was known for two years or longer and
the large majority rated their general health as fair to
good. The average PAM score of the respondents was
57.4 (SD = 14.3; see Table 2), which is relatively low
compared to other studies [5,7,15,17,20]. About 23% ofthe respondents tended to be overwhelmed and unpre-
pared to play an active role in their health care (PAM
level 1). 23% of the respondents reported to lack know-
ledge and confidence for self-management (PAM level
2); 31% of the respondents were beginning to take action
but may still lack confidence and skills to support new
behaviors (PAM level 3) and 24% of the respondents re-
ported to have confidence and to be able to perform ad-
equate behaviors in most circumstances (PAM level 4).
PAM and patient characteristics
Table 2 also shows the relationships between the PAM
score and patient characteristics. All patient characteristics
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lated to patient activation. More specifically, men, younger
people and higher educated people scored higher on pa-
tient activation. The better someone’s self-reported general
health, the higher the PAM score. Respondents who speak
Dutch at home reported higher PAM scores than those
who speak a foreign language.
PAM and health-related outcomes
The bivariate analyses show that the PAM score was re-
lated to most health-related outcomes in the expected
direction (see Table 3). We did not find significant differ-
ences in patient activation depending on smoking status,
self-checking of blood glucose level, time since last
blood sample taken to check HbA1C and time since last
blood pressure measurement by a healthcare provider.
The results of the regression analyses are presented in
Table 4. After controlling for patient characteristics, patient
activation level was significantly related to self-perceived
knowledge about diabetes, that is: knowledge about type of
diabetes, possible side-effects of medication to attend to,
and actions to take when one’s blood glucose level is too
high. In all instances, respondents in PAM level 1 reported
less knowledge about diabetes compared to respondents in
PAM level 2 to 4. No associations with activation level
were found for smoking status or self-checking the blood
glucose level. Concerning healthcare utilization, activation
level was only related with time since last feet and eye
examination. Respondents in PAM level 1 more often indi-
cated that they did not have a feet examination in the last
12 months than respondents in PAM level 2 and 4, and
they more often indicated that they did not have an eye
examination in the last 24 months than respondents in
PAM level 4. Finally, respondents in PAM level 1 more
often lacked knowledge of their HbA1C value and blood
pressure levels than respondents in PAM level 2 to 4.
Discussion
This study expands the evidence base on the relation-
ships between patient characteristics, health-related out-
comes and patient activation among people with
diabetes. The mean patient activation level of respon-
dents was 57.4 on a theoretical scale of 0–100 and re-
sembled that of the general Dutch population (56.9) and
of members with diabetes of one’s of American’s largest
not-for-profit health plans (i.e., Kaiser Permanente Med-
ical Care program, 57.1) [6,18]. Other studies reported
higher patient activation levels both among people with
diabetes and Dutch chronically-ill people [5,7,15,17,20].
In the current study, patient activation was related to
age, education level and self-reported health. Since the
participants were relatively old, low educated and often
reported a bad health, this might explain the relatively
low activation level. However, the mean activation levelas measured with the PAM seems to vary across studies
between just below 60 up to nearly 70 [5,6,11,12,15,18].
This hinders any firm statements as to whether Dutch
people with diabetes are relatively inactive when it con-
cerns their healthcare management.
As in other studies, we found that patient activation was
related to several patient characteristics [6,7,10,11,15,21,22].
More specifically, men, younger people, higher educated
people, those with a better self-reported health and those
who spoke Dutch at home reported a higher activation
level. We found no association between patient activation
and ethnicity or disease duration. One consistent finding
across studies is the positive relation between patient acti-
vation and self-reported health status. This makes sense
given the definition of patient activation; those with a
higher activation level report to have more knowledge,
skills, confidence and behaviors needed for self-managing
one’s condition or health [9,10]. Longitudinal studies are re-
quired to determine the causal direction between patient
activation and self-reported health status. It might also be
that people feel less in control as their health declines [11].
Previous studies, among diabetes and other patient
groups, revealed that patients with a higher activation
level were more likely to engage in healthy behaviors
such as regular exercise and a proper diet, to engage
in disease-specific self-management behaviors, to report
medication adherence, and to obtain preventive care
[8,11-15,23,24]. As Rask et al., we, however, found no dif-
ferences in life-style (i.e., smoking) and self-management
behaviors (i.e., self-checking blood glucose levels) depend-
ing on the patient activation level [15]. Also, we did not
find an association between the patient activation level
and most of the healthcare utilization measures after con-
trolling for relevant patient characteristics. Only the time
since the last feet and eye examination were related to the
patient activation level; those with a low activation level
(PAM level 1) more often reported they did not have an
feet examination in the last 12 or months or an eye exam-
ination in the last 24 months. The most obvious result
was that those with a high activation level (PAM level 2
to 4) more often reported to have knowledge about dia-
betes in general and of their own values on clinical indica-
tors compared to people with the lowest activation level
(PAM level 1). These results confirm once again the valid-
ity of the PAM when it comes to measuring the know-
ledge needed for self-managing one’s condition or health.
Patient activation level as measured with the PAM might
therefore especially be predictive of the knowledge people
have concerning their health and health care and to a
lesser extent of their skills and behaviors to manage their
health. Other research likewise showed that those who are
more activated are more likely to seek and find health in-
formation and to understand it better [11,23]. Since know-
ledge about diabetes and clinical values is a prerequisite
Table 3 Bivariate relations between the Patient




Life style and self-management
Smoking status 1,818 0.862
No 1,468 80.7 57.4 (14.4)
Yes 350 19.3 57.5 (13.9)
Self-checking blood glucose level 1,820 0.822
No 1,090 59.9 57.5 (14.7)
Yes 730 40.1 57.3 (13.8)
Self-perceived knowledge
Knowledge of type of diabetes 1,781 <0.001
No 352 19.8 55.2 (14.6)




No 118 9.0 51.5 (12.8)
Not really 282 21.4 52.6 (12.7)
On the whole, yes 226 17.2 56.6 (13.0)
Yes 691 52.5 60.6 (14.5)
Knowledge about what to do
when blood glucose level is too high
1,780 <0.001
No 285 16.0 54.8 (14.8)
Not really 371 20.8 54.1 (13.5)
On the whole, yes 249 14.0 56.5 (12.5)
Yes 875 49.2 59.9 (14.5)
Healthcare utilization
Blood sample to check HbA1C 1,806 0.218
Within the past 12 months 1,672 92.6 57.5 (14.3)
Over 12 months ago/Never 50 2.8 59.5 (16.1)
Don’t know 84 4.7 55.2 (13.6)
Blood sample to check cholesterol level 1,811 0.007
Within the past 12 months 1,598 88.2 57.7 (14.3)
Over 12 months ago/Never 130 7.2 56.5 (13.2)
Don’t know 83 4.6 52.8 (14.2)
Blood pressure measurement by
healthcare provider
1,821 0.132
Within the past 12 months 1,769 97.1 57.4 (14.3)
Over 12 months ago/Never 40 2.2 58.4 (16.3)
Don’t know 12 0.7 49.3 (10.6)
Feet check by doctor 1,808 0.004
Within the past 12 months 1,428 79.0 57.9 (14.3)
Over 12 months ago/Never 339 18.8 55.5 (14.2)
Don’t know 41 2.3 53.3 (14.4)
Table 3 Bivariate relations between the Patient
Activation Measure (PAM) and health-related outcomes
(Continued)
Eye examination 1,828 0.001
Within the past 24 months 1,698 92.9 57.7 (14.4)
Over 24 months ago/Never 113 6.2 53.8 (13.1)
Don’t know 17 0.9 48.9 (12.8)
Self-reported clinical values
Level of blood glucose 1,783 <0.001
Between 2% and 7% 717 40.2 59.2 (14.4)
Between 7% and 9% 514 28.8 58.3 (14.1)
Between 9% and 24% 72 4.0 54.9 (14.3)
Don’t know 480 26.9 54.4 (13.6)
Diastolic blood pressure 1,764 <0.001
Lower than 90 1,227 69.6 58.6 (14.2)
90 or higher 232 13.2 56.3 (14.3)
Don’t know 305 17.3 53.7 (13.1)
Systolic blood pressure 1,788 <0.001
Lower than 140 924 51.7 58.8 (14.4)
140 or higher 600 33.6 56.7 (13.9)
Don’t know 264 14.8 53.9 (13.3)
Note. Bold values indicate a p-value < 0.05.
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portant to identify the lower activated patients and explain
the meaning of blood glucose levels and how they can
control them in a way they can understand.
That we did not find an association between the pa-
tient activation level and most healthcare utilization
measures, could be explained by differences in the
methods used. Like in the present study, Rask et al. also
did not find a relationship between the patient activation
level and the uptake of routine checkups (except for get-
ting eye examinations) [15]. Both studies based health-
care utilization on self-report of the patient. Using
clinical data, Remmers et al. did find a relationship with
the uptake of several laboratory tests [6]. Given that clin-
ical data are probably a better indicator of actual health-
care utilization, we recommend to include this kind of
data or claims data in future research. Also the type of
care seems to be important. We looked at the utilization
of routine checkups. Both Remmers et al. (clinical data)
and Begum et al. (self-report) included the utilization of
hospital care and found that lower activated patients
were admitted to the hospital more often [6,7]. This
makes sense given that routine checkups will more often
take place on request of the healthcare provider and in-
dependent of patient characteristics. The use of unin-
tended healthcare such as a hospital admission will
probably be more affected by someone’s activation level.
Table 4 Relationship of health-related outcomes to the





Smoking status (ref: yes)
PAM level 2 −0.29 0.21 0.158
PAM level 3 0.17 0.19 0.351
PAM level 4 −0.12 0.21 0.559
Self-checking blood glucose level (ref: no)
PAM level 2 0.20 0.17 0.225
PAM level 3 0.30 0.16 0.059
PAM level 4 0.27 0.17 0.113
Self-perceived knowledge
Knowledge of type of diabetes (ref: no)
PAM level 2 0.78 0.22 <0.001
PAM level 3 0.50 0.19 0.010
PAM level 4 0.64 0.22 0.004
Knowledge about side-effects of medicines
PAM level 2 0.66 0.17 <0.001
PAM level 3 0.85 0.16 <0.001
PAM level 4 1.20 0.18 <0.001
Knowledge about what to do when blood glucose level is too high
PAM level 2 0.33 0.14 0.022
PAM level 3 0.62 0.14 <0.001
PAM level 4 0.83 0.15 <0.001
Healthcare utilization
Blood sample to check HbA1C over 12 months ago or never (ref: within
the past 12 months)
PAM level 2 −0.20 0.51 0.697
PAM level 3 0.09 0.45 0.835
PAM level 4 0.11 0.50 0.824
Blood sample to check HbA1C unknown (ref: withinthe past 12 months)
PAM level 2 −0.09 0.41 0.823
PAM level 3 0.24 0.37 0.508
PAM level 4 −0.09 0.45 0.850
Blood sample to check cholesterol level over 12 months ago or never
(ref: within the past 12 months)
PAM level 2 0.09 0.29 0.767
PAM level 3 −0.04 0.29 0.896
PAM level 4 −0.09 0.32 0.784
Blood sample to check cholesterol level unknown (ref group: within the
past 12 months)
PAM level 2 −0.68 0.41 0.102
PAM level 3 −0.45 0.37 0.221
PAM level 4 −0.75 0.46 0.107
Table 4 Relationship of health-related outcomes to the
Patient Activation Measure (PAM) (Continued)
Blood pressure measurement by healthcare provider over 12 months
ago or never (ref: within the past 12 months)
PAM level 2 −0.77 0.56 0.174
PAM level 3 −0.46 0.49 0.346
PAM level 4 −0.32 0.50 0.524
Blood pressure measurement by healthcare provider unknown (ref: within
the past 12 months)
PAM level 2 −16.00 1822.19 0.993
PAM level 3 −0.23 0.89 0.792
PAM level 4 −15.90 1734.41 0.993
Feet check by doctor over 12 months ago or never (ref: within the past
12 months)
PAM level 2 −0.44 0.20 0.025
PAM level 3 −0.29 0.18 0.105
PAM level 4 −0.58 0.21 0.005
Feet check by doctor unknown (ref: within the past 12 months)
PAM level 2 −0.27 0.64 0.669
PAM level 3 −0.12 0.58 0.838
PAM level 4 −0.83 0.74 0.262
Eye examination over 24 months ago or never (ref: within the past
24 months)
PAM level 2 −0.54 0.32 0.089
PAM level 3 −0.28 0.28 0.329
PAM level 4 −1.11 0.38 0.003
Eye examination unknown (ref: within the past 24 months)
PAM level 2 0.70 0.76 0.361
PAM level 3 −0.49 0.94 0.605
PAM level 4 −13.75 614.57 0.982
Self-reported clinical values
Level of blood glucose between 7%- 9% (ref: between 2%-7%)
PAM level 2 −0.28 0.20 0.152
PAM level 3 −0.30 0.19 0.104
PAM level 4 −0.28 0.20 0.161
Level of blood glucose between 9%- 24% (ref: between 2%-7%)
PAM level 2 −0.44 0.39 0.261
PAM level 3 −0.69 0.40 0.080
PAM level 4 −0.30 0.40 0.447
Level of blood glucose unknown (ref: between 2%-7%)
PAM level 2 −0.40 0.20 0.047
PAM level 3 −0.45 0.19 0.018
PAM level 4 −0.75 0.22 <0.001
Diastolic blood pressure 90 or higher (ref: lower than 90)
PAM level 2 −0.27 0.23 0.236
PAM level 3 −0.24 0.22 0.293
PAM level 4 −0.46 0.25 0.061
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Table 4 Relationship of health-related outcomes to the
Patient Activation Measure (PAM) (Continued)
Diastolic blood pressure unknown (ref: lower than 90)
PAM level 2 −0.74 0.22 0.001
PAM level 3 −0.45 0.20 0.028
PAM level 4 −0.99 0.24 <0.001
Systolic blood pressure 140 or higher (ref: lower than 140)
PAM level 2 −0.06 0.18 0.745
PAM level 3 0.07 0.17 0.675
PAM level 4 −0.19 0.18 0.303
Systolic blood pressure unknown (ref: lower than 140)
PAM level 2 −0.66 0.24 0.006
PAM level 3 −0.47 0.22 0.034
PAM level 4 −0.72 0.25 0.004
Note. Coefficients represent the results of individual linear regressions with
PAM level as predictor variable for each health-related outcome while
controlling for gender, age, education level, ethnicity, spoken language at
home, disease duration and general health status.
Ref = reference group.
Bold values indicate a p-value < 0.05.
Hendriks and Rademakers BMC Health Services Research 2014, 14:393 Page 8 of 9
http://www.biomedcentral.com/1472-6963/14/393Patients with a lower activation level will have more
trouble to properly manage their diabetes which may lead
to complications that need treatment in the hospital.
The current study has some limitations. The people with
diabetes were sampled and recruited via several health in-
surance companies. These companies serve the whole
population of people with diabetes in the Netherlands and
the respondents were selected randomly without excluding
any subgroups. However, the fact that people were invited
by their health insurer instead of their health care provider
may explain the relatively low response. It has been shown
that people are more inclined to respond to a question-
naire when it’s sender is more familiar or when one feels
connected to them [25]. The low response rate may have
introduced certain biases. For instance, men responded
more often than women. It also seems plausible that those
with a low patient activation level, and thus with a low level
of knowledge and skills to manage their health, might be
less likely to return the questionnaire. As a result, we might
have underestimated the relations between patient activa-
tion level and the health-related outcomes.
The study was cross-sectional impeding any conclu-
sions on the causal directionality between patient activa-
tion level and health-related outcomes. So far, only two
studies used a longitudinal design and showed that an
increase in patient activation is associated with more
self-management behaviors and that a higher patient ac-
tivation level results in better health-related outcomes
two years later [6,14]. These studies thus suggest that in-
creasing patient activation will improve health-related
behavior and outcomes.Finally, the clinical indicators were based on self-report
and only concerned the last measurement by a healthcare
provider. Therefore, we could not determine whether a
higher patient activation level was associated with better
diabetes control or better physical health. The results
did show that the recall of values on clinical indicators
was positively related to patient activation; an interest-
ing finding on its own. Comparable trends were found
for the healthcare utilization measures but here there
was a problem with statistical power. Far out most
people reported to have received checkups according to
the Dutch national guidelines. Only a small group of pa-
tients could not remember when their last checkups
had been and those patients appeared to score substan-
tially lower on patient activation.
Conclusions
People with diabetes are more and more expected to be
active patients, that is to be in charge of their own
health and the healthcare they receive. One way to ac-
complish this is by educating and training people to get
involved, be well-informed and able to adjust their be-
havior to maintain a good health. We reinforced prior
findings among a sample of Dutch people with diabetes
and showed that patient activation differs between pa-
tient subgroups. The study also yielded that patient acti-
vation level as measured with the PAM was especially
related with disease-specific knowledge and less with
health-related behavior, healthcare use and self-reported
clinical values. We provided several explanations why
the expected associations with health-related behavior
and healthcare use were not found in the present study.
The results implicate that the PAM might be an useful
instrument for clinical practice to identify people with
diabetes most in need for diabetes education. The PAM
is a short self-report questionnaire that can easily be im-
plemented in regular diabetes care. The next step is to
implement and evaluate the effectiveness of interven-
tions to increase patient activation or to tailor diabetes
care to someone’s activation level. The first results on
such interventions are promising [8,13,14].
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